Towards a hit for every target

Steve Rees; Philip Gribbon; Karen Birmingham; William P Janzen; Garry Pairaudeau

doi:10.1038/nrd.2015.19

Towards a hit for every target

Nat Rev Drug Discov. 2016 Jan;15(1):1-2. doi: 10.1038/nrd.2015.19. Epub 2015 Nov 20.

Authors

Steve Rees¹, Philip Gribbon², Karen Birmingham³, William P Janzen⁴, Garry Pairaudeau¹

Affiliations

¹ AstraZeneca, Cambridge Science Park, 310 Milton Road, Cambridge CB4 0FZ, UK.
² Fraunhofer Institute for Molecular Biology and Applied Ecology Ecology IME ScreeningPort, Schnackenburgallee 114, 22525 Hamburg, Germany.
³ AstraZeneca, 2 Kingdom Street, London W2 6BD, UK.
⁴ Lead Discovery, Epizyme, 400 Technology Square, Cambridge, Massachusetts 02139, USA.

PMID: 26585534
DOI: 10.1038/nrd.2015.19

Abstract

Technological advances coupled with novel collaborative strategies for compound sourcing and management are poised to transform the utility of high-throughput screening.

MeSH terms

Drug Discovery / methods*
Drug Industry / methods
High-Throughput Screening Assays / methods*
Public-Private Sector Partnerships